PHILLIP STOKES: Open Payments
NPI 1063010874 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 63 payments from 14 companies in 2025. Trend: 2023 $802 · 2024 $1,150 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $274 |
| PFIZER INC. | 11 | $154 |
| Lilly USA, LLC | 9 | $103 |
| Novo Nordisk Inc | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Alexion Pharmaceuticals, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 4 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
Products named: VRAYLAR, UBRELVY, MOUNJARO, NURTEC ODT, Ozempic, ELIQUIS, AIRSUPRA, Auvelity.
Industry payments across AR — which companies pay providers there.
